Skip to main content
. 2024 Jan 4;109(7):2122–2130. doi: 10.3324/haematol.2023.284445

Figure 1.

Figure 1.

Two-years survival outcomes after matched unrelated donor and haploidential hematopoietic cell transplantation after matched pair analysis. Two-year leukemia-free survival (LFS), overall survival (OS), relapse incidence (RI) and non-relapse mortality (NRM) after matched unrelated donor (MUD) and haploidential hematopoietic cell transplantation in children with acute myleoid leukemia after matched pair analysis.